Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Details)

v3.24.3
Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Details) - shares
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 18,111,735 18,306,366
Stock Options    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 940,211 1,746,177
Unvested Restricted Stock Units    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 3,029,226 2,417,891
Warrants    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 14,142,298 14,142,298